Piper Jaffray Starts Corcept Therapeutics (CORT) at Overweight

January 3, 2013 4:59 PM EST
Get Alerts CORT Hot Sheet
Price: $5.28 +0.76%

Rating Summary:
    7 Buy, 4 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 35 | Down: 25 | New: 13
Trade CORT Now!
Join SI Premium – FREE
Piper Jaffray initiates coverage on Corcept Therapeutics (NASDAQ: CORT) with a Overweight. PT $4.00.

For an analyst ratings summary and ratings history on Corcept Therapeutics click here. For more ratings news on Corcept Therapeutics click here.

Shares of Corcept Therapeutics closed at $1.48 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

Piper Jaffray

Add Your Comment